当前位置:首页 - 行情中心 - 和元生物(688238) - 财务分析

和元生物

(688238)

  

流通市值:35.26亿  总市值:35.70亿
流通股本:6.41亿   总股本:6.49亿

和元生物(688238)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.53亿元,每股收益-0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益135738.54万元,未分配利润-65343.38万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产199817.82万元,负债64079.28万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入50,540,466.83267,696,887.26180,353,622.06119,854,988.98
营业总成本105,516,677.95492,112,471.65341,998,749.46223,076,169.16
其他经营收益
营业利润-53,240,091.47-232,757,426.93-159,788,844.3-102,473,388.34
利润总额-53,239,889.99-233,079,842.65-160,131,214.55-102,771,640.68
净利润-53,064,353.68-234,810,012.67-162,017,387.18-104,481,169.78
每股收益
其他综合收益-90,380.132,026,920.042,085,099.252,124,667.76
综合收益总额-53,154,733.81-232,783,092.63-159,932,287.93-102,356,502.02
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计473,392,047.95547,155,399.62536,852,077.65529,235,254.03
非流动资产:
非流动资产合计1,524,786,198.411,544,636,748.31,580,119,633.921,590,217,590.64
资产总计1,998,178,246.362,091,792,147.922,116,971,711.572,119,452,844.67
流动负债:
流动负债合计368,905,663.89443,953,560.71430,580,658.95380,408,565.34
非流动负债:
非流动负债合计271,887,182.47239,733,422.95205,120,144.83201,851,848.15
负债合计640,792,846.36683,686,983.66635,700,803.78582,260,413.49
所有者权益(或股东权益):
归属于母公司股东权益合计1,355,707,245.641,408,097,480.631,481,419,704.381,537,348,193.9
股东权益合计1,357,385,4001,408,105,164.261,481,270,907.791,537,192,431.18
负债和股东权益合计1,998,178,246.362,091,792,147.922,116,971,711.572,119,452,844.67
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计54,380,664.07286,218,578.08192,949,481.13113,804,199.64
经营活动现金流出小计120,452,896.78388,813,523.04303,530,296.52202,303,817.23
经营活动产生的现金流量净额-66,072,232.71-102,594,944.96-110,580,815.39-88,499,617.59
投资活动产生的现金流量:
投资活动现金流入小计30,017,532.18351,050,379.83260,573,842.54209,664,967.65
投资活动现金流出小计113,305,989.08461,581,348.39391,247,921.3291,056,857.78
投资活动产生的现金流量净额-83,288,456.9-110,530,968.56-130,674,078.76-81,391,890.13
筹资活动产生的现金流量:
筹资活动现金流入小计116,650,000280,000,000234,903,753.27200,000,000
筹资活动现金流出小计120,992,491.76211,196,271.02193,846,989.46182,568,483.3
筹资活动产生的现金流量净额-4,342,491.7668,803,728.9841,056,763.8117,431,516.7
汇率变动对现金及现金等价物的影响-50,528.32-20,263.68-66,210.72-23,479.12
现金及现金等价物净增加额-153,753,709.69-144,342,448.22-200,264,341.06-152,483,470.14
期末现金及现金等价物余额136,798,093.92290,551,803.61234,629,910.77282,410,781.69
补充资料:
现金及现金等价物的净增加额--144,342,448.22--152,483,470.14
最新报告期:2026-04-21
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中金公司俞波,张琎,吴婉桦-0.30-0.20--2026-04-21
TOP↑